NY Presbyterian Hosp-MRI

Dr. Harsimran Singh grew up in Lancaster, Pennsylvania, earning his undergraduate education in Molecular Biology from Princeton University. He traveled abroad to complete a Masters in Health Care Policy at the London School of Hygiene & Tropical Medicine. He received his medical degree from Yale University School of Medicine. He completed his internship and residency training in Internal Medicine at University of California, San Francisco. He then returned back east to complete his fellowship training and board certification in both Cardiovascular Diseases and Interventional Cardiology from Columbia University - New York Presbyterian Hospital. Finally, he obtained specialized training in Adult Congenital Heart Disease (ACHD) and Structural Interventional Cardiology in Canada at Toronto General Hospital & The Hospital for Sick Children.Dr. Singh joined the full-time faculty at Weill Cornell Medical College - New York Presbyterian Hospital as a specialist in ACHD and Interventional Cardiology. Dr. Singh is the Director of Adult Congenital Heart Disease and is the David S. Blumenthal Assistant Professor of Medicine. He also serves as the Director of the Cardiovascular Fellowship training program at Weill Cornell - New York Presbyterian Hospital.As an interventional cardiologist, Dr. Singh specializes in percutaneous (minimally invasive) cardiac interventions for coronary, congenital / structural, and valvular disease. His clinical cardiology practice consists of patients with acquired and congenital heart conditions. Dr. Singh speaks Hindi, Punjabi, and Spanish.

Weill Cornell Medicine is a prestigious healthcare institution affiliated with NewYork-Presbyterian Hospital, dedicated to delivering exceptional patient care and advancing medical education. With a commitment to providing individualized treatment, the organization boasts a network of over 2,000 doctors and access to a wide range of clinical services, including digital health options for convenience. Renowned for its dedication to groundbreaking biomedical research, Weill Cornell Medicine strives to educate the next generation of exceptional healthcare professionals. The institution prioritizes patient satisfaction and safety, ensuring that each patient receives compassionate care tailored to their unique needs. Generated from the website

The Rogosin Institute, established in 1983, is a renowned center in New York, NY, dedicated to redefining kidney diagnosis, treatment, and management. With a mission to provide the highest quality of care, the institute combines cutting-edge treatment options, innovative clinical research, and a team of compassionate physicians to transform the lives of patients suffering from chronic kidney disease. Driven by a commitment to holistic well-being, Rogosin works closely with patients, families, and community organizations to raise awareness about kidney disease, encourage healthy behaviors, and empower individuals to take charge of their healthcare decisions. Through their Wellness Program and partnerships with community-based organizations, Rogosin strives to improve health outcomes and create better healthcare policies. With a focus on clinical research, the institute is at the forefront of finding new treatments and therapies for various health conditions, making it a leading center in the field.Generated from the website